{"id":6501,"date":"2019-07-24T10:17:00","date_gmt":"2019-07-24T02:17:00","guid":{"rendered":"https:\/\/nhri.raise-up.com.tw\/dbpr807\/"},"modified":"2021-09-02T17:51:04","modified_gmt":"2021-09-02T09:51:04","slug":"dbpr807","status":"publish","type":"post","link":"https:\/\/ttic.nhri.edu.tw\/en\/dbpr807\/","title":{"rendered":"Technology Available for Industry-Academia Collaboration or Technology Licensing. \u201cDBPR807: a CXCR4-Targeted Antagonist\u201d(2019\/07\/24)"},"content":{"rendered":"\r\n<h2 class=\"wp-block-heading\">Title:<\/h2>\r\n<p>NHRI technology, \u201cDBPR807: a CXCR4-Targeted Antagonist\u201d (abbreviated as \u201cThe Technology\u201d) available for industry-academia collaboration or technology licensing.<\/p>\r\n<h2>Description:<\/h2>\r\n<p>DBPR807 is a potent antagonist targeting CXCR4 receptors for medical treatment of peripheral blood stem cell transplantation, hepatocellular carcinoma and acute myocardial infarction.<\/p>\r\n<h2>Potential collaboration partner qualifications:<\/h2>\r\n<ol>\r\n<li>be incorporated and approved by law and does not have any record of misconduct or conviction for any offense<\/li>\r\n<li>better to have related experience and skills for developing The Technology<\/li>\r\n<li>better to have experience of international collaboration and clinical trial<\/li>\r\n<li>be willing to provide long-term investment<\/li>\r\n<\/ol>\r\n<h2>Registration\uff1a<\/h2>\r\n<p>Please contact to Mr. Hua-Hsuan Liang (Address: Technology Transfer and Incubation Center, National Health Research Institutes, 35 Keyan Road, Zhunan Town, Miaoli County 35053, Taiwan, R.O.C., Tel: +88637-246166#33206, E-mail: huahsuan@nhri.org.tw).<\/p>\r\n<h2>Other:<\/h2>\r\n<ol>\r\n<li>If The Technology has been exclusively licensed, this announcement will automatically invalid.<\/li>\r\n<li>NHRI retains the right to modify and terminate this announcement.<\/li>\r\n<li>For detailed status of The Technology, please contact to the case officer.<\/li>\r\n<\/ol>\r\n<p>Attachments:<br \/>I: <a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2019\/07\/20190723-I-DBPR807-Announcement.pdf\" aria-label=\"Announcement (\u5728\u65b0\u5206\u9801\u4e2d\u958b\u555f)\">Announcement<\/a><br \/>II: <a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2019\/09\/att2_DBPR807_Licensing_-Proposal_EN-20190723.doc\" aria-label=\"Licensing Proposal (\u5728\u65b0\u5206\u9801\u4e2d\u958b\u555f)\">Licensing Proposal<\/a><br \/>III:<a href=\"https:\/\/ttic.nhri.edu.tw\/wp-content\/uploads\/2019\/07\/20190723-III-DBPR807-Industry-Academia-Collaboration-Proposal.doc\" aria-label=\" Industry-Academia Collaboration Proposal (\u5728\u65b0\u5206\u9801\u4e2d\u958b\u555f)\"> Industry-Academia Collaboration Proposal<\/a><\/p>\r\n\r\n\r\n\r\n\r\n","protected":false},"excerpt":{"rendered":"<p>Title: NHRI technology, \u201cDBPR807: a CXCR4-Targeted Antagonist\u201d (abbreviated as \u201cThe Technology\u201d) available for industry-academia collaboration or technology licensing. Description: DBPR807 is a potent antagonist targeting CXCR4 receptors for medical treatment of peripheral blood stem cell transplantation, hepatocellular carcinoma and acute myocardial infarction. Potential collaboration partner qualifications: be incorporated and approved by law and does not &hellip;<\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/ttic.nhri.edu.tw\/en\/dbpr807\/\"> <span class=\"screen-reader-text\">Technology Available for Industry-Academia Collaboration or Technology Licensing. \u201cDBPR807: a CXCR4-Targeted Antagonist\u201d(2019\/07\/24)<\/span> Read More &raquo;<\/a><\/p>\n","protected":false},"author":5,"featured_media":6492,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[147,148],"tags":[],"table_tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/posts\/6501"}],"collection":[{"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/comments?post=6501"}],"version-history":[{"count":3,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/posts\/6501\/revisions"}],"predecessor-version":[{"id":6782,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/posts\/6501\/revisions\/6782"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/media\/6492"}],"wp:attachment":[{"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/media?parent=6501"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/categories?post=6501"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/tags?post=6501"},{"taxonomy":"table_tags","embeddable":true,"href":"https:\/\/ttic.nhri.edu.tw\/en\/wp-json\/wp\/v2\/table_tags?post=6501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}